This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
KGI | Ann:Audited Annual Report 2024 (Price Sensitive) | 17/09/24 | 0 | 1 | |||
|
|||||||
KGI | Ann:Unaudited NTA August 2024 (Price Sensitive) | 17/09/24 | 0 | 1 | |||
|
|||||||
KGI | Ann:Notice of general meeting (Price Sensitive) | 11/09/24 | 0 | 1 | |||
|
|||||||
KGI | Ann:NTA valuation for February 2019 (Price Sensitive) | 18/03/19 | 0 | 395 | |||
|
|||||||
KGI | Ann:Audited half-year financial report to 31 December 2018 (Price Sensitive) | 27/02/19 | 0 | 203 | |||
|
|||||||
KGI | Ann:NTA valuation for January 2019 (Price Sensitive) | 22/02/19 | 0 | 231 | |||
|
|||||||
KGI | Ann:NTA Valuation for December 2018 (Price Sensitive) | 16/01/19 | 0 | 325 | |||
|
|||||||
KGI | Ann:NTA Valuation for November 2018 (Price Sensitive) | 14/12/18 | 0 | 341 | |||
|
See All Discussions
Timeline
|
|||||
|
|||||
|
|||||